Assessing the quality of care for paediatric depression and anxiety in Australia: A population-based sample survey

The Australian and New Zealand Journal of Psychiatry
Louise A EllisJeffrey Braithwaite

Abstract

We examine the prevalence of quality care (as measured by adherence to recommendations in clinical practice guidelines) for Australian paediatric patients (⩽15 years) with depression and/or anxiety, using data from the CareTrack Kids study; a population-based study of the quality of healthcare practice in inpatient and ambulatory healthcare settings. A multistage stratified sample identified records of 6689 children. Of these, 156 records were identified for depression and 356 for anxiety. These were assessed for adherence to 15 depression and 13 anxiety indicators, respectively, using a review of medical records. Adherence to assessment and management guidelines was low for both conditions: assessment bundle (depression = 33%, 95% confidence interval = [20, 48]; anxiety = 54%, 95% confidence interval = [43, 64] and depression management bundle = 35%, 95% confidence interval = [15, 60]). Across both conditions, the highest adherence was recorded for indicators that addressed prescription of medications (e.g. venlafaxine, 100%; benzodiazepines, 100%; selective serotonin reuptake inhibitor, 94% and antidepressants, 91%), while compliance was the lowest for ensuring children with depression had an emergency safety plan (44%), info...Continue Reading

References

Feb 7, 2001·Archives of General Psychiatry·A S YoungK B Wells
Jan 5, 2002·American Journal of Public Health·Philip S WangRonald C Kessler
Sep 12, 2002·Child and Adolescent Psychiatric Clinics of North America·Boris BirmaherDavid Brent
Dec 11, 2002·BMC Health Services Research·Carlos M SotoSteven R Simon
Jun 26, 2003·Journal of General Internal Medicine·Jeffrey M PyneJohn Fortney
Jan 24, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Sucheta D ConnollyUNKNOWN Work Group on Quality Issues
Feb 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·A FernándezJ Alonso
Sep 6, 2007·Annals of Internal Medicine·Kimberly A HepnerLisa V Rubenstein
Oct 12, 2007·The New England Journal of Medicine·Rita Mangione-SmithElizabeth A McGlynn
Jan 25, 2008·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Teresa L KramerJames M Robbins
Feb 26, 2008·Journal of Child and Adolescent Psychopharmacology·Supriya K BhatiaChristopher J Kratochvil
Jun 14, 2008·Journal of Developmental and Behavioral Pediatrics : JDBP·Amy CheungAnthony Levitt
Sep 9, 2009·Pediatrics·Lisa H JaycoxM Audrey Burnam
Jan 6, 2010·Journal of General Internal Medicine·Marijn A PrinsJozien M Bensing
Mar 23, 2010·General Hospital Psychiatry·Anna FernándezAntoni Serrano-Blanco
May 29, 2012·Pharmacoepidemiology and Drug Safety·Falk HoffmannChristian J Bachmann
Jul 17, 2012·The Medical Journal of Australia·William B RuncimanJeffrey Braithwaite
Jul 17, 2012·The Medical Journal of Australia·William B RuncimanJeffrey Braithwaite
Sep 23, 2014·Acta Psychiatrica Scandinavica·M K van DijkA J L M van Balkom
Oct 18, 2016·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Magenta B SimmonsSarah E Hetrick
Jun 2, 2017·The Australian and New Zealand Journal of Psychiatry·Yu-Chen LeeCathrine Mihalopoulos
Mar 21, 2018·JAMA : the Journal of the American Medical Association·Jeffrey BraithwaiteStephen Muething

❮ Previous
Next ❯

Software Mentioned

SAS
CTK

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.